Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles

被引:75
作者
Hu, LianDong [1 ]
Xing, Qianbin [1 ]
Meng, Jian [2 ]
Shang, Chuang [1 ]
机构
[1] Hebei Univ, Sch Pharm, Baoding 071002, Hebei Province, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
来源
AAPS PHARMSCITECH | 2010年 / 11卷 / 02期
关键词
absorption; bioavailability; cryptotanshinone; high-pressure homogenization; solid lipid nanoparticles; TANSHINONE-IIA; ABSORPTION; METABOLITE; PLASMA;
D O I
10.1208/s12249-010-9410-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, solid lipid nanoparticles (SLNs) were successfully prepared by an ultrasonic and high-pressure homogenization method to improve the oral bioavailability of the poorly water-soluble drug cryptotanshinone (CTS). The particle size and distribution, drug loading capacity, drug entrapment efficiency, zeta potential, and long-term physical stability of the SLNs were characterized in detail. A pharmacokinetic study was conducted in rats after oral administration of CTS in different SLNs, and it was found that the relative bioavailability of CTS in the SLNs was significantly increased compared with that of a CTS-suspension. The incorporation of CTS in SLNs also markedly changes the metabolism behavior of CTS to tanshinone IIA. These results indicate that CTS absorption is enhanced significantly by employing SLN formulations, and SLNs represent a powerful approach for improving the oral absorption of poorly soluble drugs.
引用
收藏
页码:582 / 587
页数:6
相关论文
共 25 条
  • [1] Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems
    Balakrishnan, Prabagar
    Lee, Beom-Jin
    Oh, Dong Hoon
    Kim, Jong Oh
    Lee, Young-Im
    Kim, Dae-Duk
    Jee, Jun-Pil
    Lee, Yong-Bok
    Woo, Jong Soo
    Yong, Chul Soon
    Choi, Han-Gon
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 374 (1-2) : 66 - 72
  • [2] Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation
    Brocks, DR
    Betageri, GV
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) : 1049 - 1053
  • [3] CHEN Y, 2009, INT J PHARMACEUT, V376, P53
  • [4] Cytotoxic and aromatic constituents from Salvia miltiorrhiza
    Don, MJ
    Shen, CC
    Syu, WJ
    Ding, YH
    Sun, CM
    [J]. PHYTOCHEMISTRY, 2006, 67 (05) : 497 - 503
  • [5] Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS)
    Hao, HP
    Wang, GJ
    Li, P
    Li, J
    Ding, ZQ
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (02) : 382 - 388
  • [6] Solid lipid namoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
    Hu, LD
    Tang, X
    Cui, FD
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (12) : 1527 - 1535
  • [7] Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro
    Hur, JM
    Shim, JS
    Jung, HJ
    Kwon, HJ
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (02) : 133 - 137
  • [8] Improvement of physicochemical properties of N-4472 Part II: characterization of N-4472 microemulsion and the enhanced oral absorption
    Itoh, K
    Matsui, S
    Tozuka, Y
    Oguchi, T
    Yamamoto, K
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 246 (1-2) : 75 - 83
  • [9] Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression
    Jin, Dao-Zhong
    Yin, Lin-Lin
    Ji, Xin-Quan
    Zhu, Xing-Zu
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 549 (1-3) : 166 - 172
  • [10] Inhibition of interleukin-12 and interferon-γ production in immune cells by tanshinones from Salvia miltiorrhiza
    Kang, BY
    Chung, SW
    Kim, SH
    Ryu, SY
    Kim, TS
    [J]. IMMUNOPHARMACOLOGY, 2000, 49 (03): : 355 - 361